Cyclic amidines as benzamide bioisosteres: EPC synthesis and SAR studies leading to the selective dopamine D4 receptor agonist FAUC 312

Bioorg Med Chem Lett. 2003 Mar 10;13(5):851-4. doi: 10.1016/s0960-894x(03)00004-0.

Abstract

Investigation of conformationally restricted benzamide bioisosteres led to the chiral phenyltetrahydropyrimidine derivative ent2a (FAUC 312) displaying strong and highly selective dopamine D4 receptor binding (K(i(high))=1.5 nM). Mitogenesis experiments indicated 83% ligand efficacy when compared to the unselective agonist quinpirole. The target compounds of type 2 and 3 were synthesized in enantiopure form starting from asparagine.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amidines / chemistry*
  • Animals
  • Benzamides / chemistry*
  • CHO Cells
  • Cattle
  • Clozapine / pharmacology
  • Cricetinae
  • Cyclization
  • Humans
  • Kinetics
  • Ligands
  • Mitogens / pharmacology
  • Mitosis / drug effects
  • Piperazines / chemical synthesis*
  • Piperazines / pharmacology
  • Pyrimidines / chemical synthesis*
  • Pyrimidines / chemistry
  • Pyrimidines / pharmacology*
  • Quinpirole / pharmacology
  • Receptors, Dopamine D2 / agonists*
  • Receptors, Dopamine D2 / metabolism
  • Receptors, Dopamine D4
  • Stereoisomerism
  • Structure-Activity Relationship

Substances

  • Amidines
  • Benzamides
  • DRD4 protein, human
  • FAUC 312
  • Ligands
  • Mitogens
  • Piperazines
  • Pyrimidines
  • Receptors, Dopamine D2
  • Receptors, Dopamine D4
  • Quinpirole
  • benzamide
  • Clozapine